References
- Eagle KA. Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). Am Heart J. 2009 Feb;157(2):319–326.
- Shan Y, Li J, Wang Y, et al. Aortic shear stress in patients with bicuspid aortic valve with stenosis and insufficiency. J Thorac Cardiovasc Surg. 2017 Jun;153(6):1263–1272. doi:https://doi.org/10.1016/j.jtcvs.2016.12.059.
- Della Corte A, Michelena HI, Citarella A, et al. Risk stratification in Bicuspid Aortic Valve aortopathy: emerging Evidence and Future perspectives. Curr Probl Cardiol. 2019;100428. doi:https://doi.org/10.1016/j.cpcardiol.2019.06.002.
- Melvinsdottir IH, Lund SH, Agnarsson BA, et al. The incidence and mortality of acute thoracic aortic dissection: results from a whole nation study. Eur J Cardiothorac Surg. 2016;50(6):1111–1117. doi:https://doi.org/10.1093/ejcts/ezw235.
- Lindeman JH, Matsumura JS. Pharmacologic management of aneurysms. Circ Res. 2019;124(4):631–646. doi:https://doi.org/10.1161/CIRCRESAHA.118.312439.
- Kallenbach K, Kojic D, Oezsoez M, et al. Treatment of ascending aortic aneurysms using different surgical techniques: a single-centre experience with 548 patients. Eur J Cardiothorac Surg. 2013 Aug;44(2):337–345. doi:https://doi.org/10.1093/ejcts/ezs661.
- Goldfinger JZ, Halperin JL, Marin ML, et al. Thoracic aortic aneurysm and dissection. JACC. 2014;64(16):1725–1739. doi:https://doi.org/10.1016/j.jacc.2014.08.025.
- Jeremy RW, Robertson E, Lu Y, et al. Perturbations of mechanotransduction and aneurysm formation in heritable aortopathies. Int J Cardiol. 2013 Oct 25;169(1):7–16. doi:https://doi.org/10.1016/j.ijcard.2013.08.056.
- Halushka MK, Angelini A, Bartoloni G, et al. Consensus statement on surgical pathology of the aorta from the society for cardiovascular Pathology and the association For european cardiovascular Pathology: II. noninflammatory degenerative diseases - nomenclature and diagnostic criteria. Cardiovasc Pathol. 2016 May-Jun;25(3):247–257. doi:https://doi.org/10.1016/j.carpath.2016.03.002.
- Humphrey JD, Schwartz MA, Tellides G, et al. Role of mechanotransduction in vascular biology. Circ Res. 2015;116(8):1448–1461. doi:https://doi.org/10.1161/CIRCRESAHA.114.304936.
- Verhagen JMA, Kempers M, Cozijnsen L, et al. Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree relatives. Int J Cardiol. 2018;258:243–248. doi:https://doi.org/10.1016/j.ijcard.2018.01.145.
- Sies H. Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997;82(2):291–295.
- Chen Q, Wang Q, Zhu J, et al. Reactive oxygen species: key regulators in vascular health and diseases. Br J Pharmacol. 2018;175(8):1279–1292. doi:https://doi.org/10.1111/bph.13828.
- Ho E, Karimi Galougahi K, Liu C-C, et al. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 2013;1(1):483–491. doi:https://doi.org/10.1016/j.redox.2013.07.006.
- Mendiola AS, Ryu JK, Bardehle S, et al. Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation.Nat Immunol. 2020;21(5):513–524. doi:https://doi.org/10.1038/s41590-020-0654-0.
- Yang HH, van Breemen C, Chung AW. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress. Vascul Pharmacol. 2010;52(1-2):37–45. doi:https://doi.org/10.1016/j.vph.2009.10.005.
- Jiménez-Altayó F, Meirelles T, Crosas-Molist E, et al. Redox stress in Marfan syndrome: dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm. Free Radic Biol Med. 2018;118:44–58. doi:https://doi.org/10.1016/j.freeradbiomed.2018.02.023.
- Carta L, Smaldone S, Zilberberg L, et al. P38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J Biol Chem. 2009;284(9):5630–5636. doi:https://doi.org/10.1074/jbc.M806962200.
- Guido M, Debbas V, Salemi V, et al. Effect of the antioxidant lipoic acid in aortic phenotype in a Marfan syndrome mouse model. Oxid Med Cell Longev. 2018. doi:https://doi.org/10.1155/2018/3967213.
- Soto ME, Soria-Castro E, Lans VG, et al. Analysis of oxidative stress enzymes and structural and functional proteins on human aortic tissue from different aortopathies. Oxid Med Cell Longev. 2014. doi:https://doi.org/10.1155/2014/760694.
- Billaud M, Phillippi JA, Kotlarczyk MP, et al. Elevated oxidative stress in the aortic media of patients with bicuspid aortic valve. J Thorac Cardiovasc Surg. 2017. doi:https://doi.org/10.1016/j.jtcvs.2017.05.065.
- Phillippi JA, Hill JC, Billaud M, et al. Bicuspid Aortic Valve morphotype correlates With regional antioxidant gene expression profiles in the proximal ascending aorta. Ann Thorac Surg. 2017;104(1):79–89. doi:https://doi.org/10.1016/j.athoracsur.2016.10.039.
- Phillippi JA, Billaud M, Hill JC, et al. Elevated oxidative stress induces smooth muscle cell death via superoxide anion in Bicuspid Aortic valve-associated aortopathy [abstract ]. Circulation. 2015;132(Suppl 3):A19655–A19655.
- Phillippi JA, Klyachko EA, Kenny JP, et al. Basal and oxidative stress–induced expression of metallothionein Is decreased in ascending aortic aneurysms of Bicuspid Aortic Valve patients. Circulation. 2009;119(18):2498–2506. doi:https://doi.org/10.1161/circulationaha.108.770776.
- Phillippi JA, Eskay MA, Kubala AA, et al. Altered oxidative stress responses and increased type I collagen expression in Bicuspid Aortic Valve patients. Ann Thorac Surg. 2010;90(6):1893–1898. doi:https://doi.org/10.1016/j.athoracsur.2010.07.069.
- Soto ME, Manzano-Pech LG, Guarner-Lans V, et al. Oxidant/antioxidant profile in the thoracic aneurysm of patients with the Loeys-Dietz syndrome. Oxid Med Cell Longev. 2020. doi:https://doi.org/10.1155/2020/5392454.
- Landis BJ, Corvera Joel S, Idrees M, et al. COQ8B: a candidate genetic modifier of oxidative metabolism and thoracic aortic aneurysm severity [abstract]. Circulation. 2018;138(Suppl_1):A14841–A14841. doi:https://doi.org/10.1161/circ.138.suppl_1.14841.
- Drummond GR, Selemidis S, Griendling KK, et al. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov. 2011;10(6):453. doi:https://doi.org/10.1038/nrd3403.
- Dolan JM, Meng H, Singh S, et al. High fluid shear stress and spatial shear stress gradients affect endothelial proliferation, survival, and alignment. Ann Biomed Eng. 2011 Jun;39(6):1620–1631. doi:https://doi.org/10.1007/s10439-011-0267-8.
- Branchetti E, Poggio P, Sainger R, et al. Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. Cardiovasc Res. 2013;100(2):316–324. doi:https://doi.org/10.1093/cvr/cvt205.
- Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337–339. doi:https://doi.org/10.1038/352337a0.
- van Karnebeek CD, Naeff MS, Mulder BJ, et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child. 2001;84(2):129–137. doi:https://doi.org/10.1136/adc.84.2.129.
- Pyeritz RE. Etiology and pathogenesis of the Marfan syndrome: current understanding. Ann Cardiothorac Surg. 2017;6(6):595–598.
- Fiorillo C, Becatti M, Attanasio M, et al. Evidence for oxidative stress in plasma of patients with Marfan syndrome. Int J Cardiol. 2010;145(3):544–546. doi:https://doi.org/10.1016/j.ijcard.2010.04.077.
- Emrich F, Penov K, Arakawa M, et al. Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation. J Cell Mol Med. 2019;23(10):7000–7009. doi:https://doi.org/10.1111/jcmm.14587.
- Osler W. The Bicuspid condition of the Aortic Valves. Wm. J. Dornan; 1886.
- Barker AJ, Markl M, Bürk J, et al. Bicuspid aortic valve is associated with altered wall shear stress in the ascending aorta. Circ Cardiovasc Imaging. 2012;5(4):457–466. doi:https://doi.org/10.1161/CIRCIMAGING.112.973370.
- Bollache E, Guzzardi DG, Sattari S, et al. Aortic-valve mediated wall shear stress is heterogeneous and predicts regional aortic elastic fiber thinning in bicuspid aortic valve-associated aortopathy. J Thorac Cardiovasc Surg. 2018. doi:https://doi.org/10.1016/j.jtcvs.2018.05.095.
- Hope MD, Hope TA, Crook SES, et al. 4D flow CMR in assessment of valve-related ascending aortic disease. JACC: Cardiovas Imaging. 2011;4(7):781–787. doi:https://doi.org/10.1016/j.jcmg.2011.05.004.
- Piatti F, Sturla F, Bissell MM, et al. 4D flow analysis of BAV-related fluid-dynamic alterations: evidences of wall shear stress alterations in absence of clinically-relevant aortic anatomical remodeling. Front Physiol. 2017;8(441). doi:https://doi.org/10.3389/fphys.2017.00441.
- Meng YH, Tian C, Liu L, et al. Elevated expression of connective tissue growth factor, osteopontin and increased collagen content in human ascending thoracic aortic aneurysms. Vascular. 2014 Feb;22(1):20–27. doi:https://doi.org/10.1177/1708538112472282.
- Wang X, LeMaire SA, Chen L, et al. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation. 2006;114(1_supplement):I-200–I-205. doi:https://doi.org/10.1161/CIRCULATIONAHA.105.000240.
- Lei XG, Zhu J-H, Cheng W-H, et al. Paradoxical roles of antioxidant enzymes: basic mechanisms and health implications. Physiol Rev. 2015;96(1):307–364. doi:https://doi.org/10.1152/physrev.00010.2014.
- Zúñiga-Muñoz AM, Pérez-Torres I, Guarner-Lans V, et al. Glutathione system participation in thoracic aneurysms from patients with Marfan syndrome. VASA. 2017;46(3):177–186. doi:https://doi.org/10.1024/0301-1526/a000609.
- Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1–12. doi:https://doi.org/10.1016/j.mam.2008.08.006.
- Srdić-Rajić T, Konić Ristić A. Antioxidants: role on health and prevention. In: Caballero B, Finglas PM, Toldrá F, editor. Encyclopedia of food and health. Oxford: Academic Press; 2016. p. 227–233.
- Asensi M, Sastre J, Pallardo FV, et al. Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol. 1999;299:267–276. doi:https://doi.org/10.1016/s0076-6879(99)99026-2.
- Pizzorno J. Glutathione!. Integr Med (Encinitas). 2014;13(1):8–12.
- Teskey G, Abrahem R, Cao R, et al. Chapter five - glutathione as a marker for human disease. Adv Clin Chem. 2018;87:141–159.
- Krizkova S, Kepinska M, Emri G, et al. Microarray analysis of metallothioneins in human diseases—a review. J Pharm Biomed. 2016;117:464–473. doi:https://doi.org/10.1016/j.jpba.2015.09.031.
- Nath R, Kumar D, Li T, et al. Metallothioneins, oxidative stress and the cardiovascular system. Toxicology. 2000;155(1):17–26. doi:https://doi.org/10.1016/S0300-483X(00)00273-0.
- Takahashi S. Positive and negative regulators of the metallothionein gene (review). Mol Med Rep. 2015;12(1):795–799. doi:https://doi.org/10.3892/mmr.2015.3459.
- Maleckaite R, Zalimas A, Bakavicius A, et al. DNA methylation of metallothionein genes is associated with the clinical features of renal cell carcinoma. Oncol Rep. 2019;41(6):3535–3544. doi:https://doi.org/10.3892/or.2019.7109.
- Liao M, Liu Z, Bao J, et al. A proteomic study of the aortic media in human thoracic aortic dissection: Implication for oxidative stress. J Thorac Cardiovasc Surg. 2008;136(1):65–72. doi:https://doi.org/10.1016/j.jtcvs.2007.11.017.
- Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002;33(3):337–349. doi:https://doi.org/10.1016/S0891-5849(02)00905-X.
- Maiellaro-Rafferty K, Weiss D, Joseph G, et al. Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H355–H362. doi:https://doi.org/10.1152/ajpheart.00040.2011.
- Parastatidis I, Weiss D, Joseph G, et al. Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2389–2396. doi:https://doi.org/10.1161/atvbaha.113.302175.
- Cao SS, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxid Redox Signal. 2014;21(3):396–413. doi:https://doi.org/10.1089/ars.2014.5851.
- Yu E, Foote K, Bennett M. Mitochondrial function in thoracic aortic aneurysms. Cardiovasc Res. 2018;114(13):1696–1698. doi:https://doi.org/10.1093/cvr/cvy180.
- van der Pluijm I, Burger J, van Heijningen PM, et al. Decreased mitochondrial respiration in aneurysmal aortas of Fibulin-4 mutant mice is linked to PGC1A regulation. Cardiovasc Res. 2018;114(13):1776–1793. doi:https://doi.org/10.1093/cvr/cvy150.
- Argraves WS, Greene LM, Cooley MA, et al. Fibulins: physiological and disease perspectives. EMBO Rep 2003 Dec;4(12):1127–1131. doi:https://doi.org/10.1038/sj.embor.7400033.
- Dao VT-V, Elbatreek MH, Altenhöfer S, et al. Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation. Free Radic Biol Med. 2020;148:60–69. doi:https://doi.org/10.1016/j.freeradbiomed.2019.12.038.
- Urner S, Ho F, Jha JC, et al. NADPH oxidase inhibition: preclinical and clinical studies in diabetic complications. Antioxid Redox Signal. 2020;33(6):415–434. doi:https://doi.org/10.1089/ars.2020.8047.
- Elbatreek MH, Mucke H, Schmidt H. NOX inhibitors: from bench to naxibs to bedside. Handb Exp Pharmacol. 2020. doi:https://doi.org/10.1007/164_2020_387.
- Guzik TJ, Sadowski J, Guzik B, et al. Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):333–339. doi:https://doi.org/10.1161/01.Atv.0000196651.64776.51.
- Li L, Yang X, Dusting GJ, et al. Increased oxidative stress and xanthine oxidase activity in human ruptured cerebral aneurysms. Neuroradiol J. 2007 Oct 31;20(5):545–550. doi:https://doi.org/10.1177/197140090702000512.
- McNally JS, Michael ED, Don PG, et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol. 2003;285(6):2290–2297. doi:https://doi.org/10.1152/ajpheart.00515.2003.
- Humphrey JD, Schwartz MA, Tellides G, et al. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circ Res. 2015;116(8):1448–1461. doi:https://doi.org/10.1161/CIRCRESAHA.114.304936.
- Nogi M, Satoh K, Sunamura S, et al. Small GTP-binding protein GDP dissociation stimulator prevents thoracic aortic aneurysm formation and rupture by phenotypic preservation of aortic smooth muscle cells. Circulation. 2018;138(21):2413–2433. doi:https://doi.org/10.1161/CIRCULATIONAHA.118.035648.
- Renard M. SmgGDS, a new piece in the thoracic aortic aneurysm and dissection puzzle. J Thorac Dis. 2018 Nov;10(Suppl 33): S4133–S4136.
- Aoki H. Challenges in thoracic aortic aneurysm and dissection. J Thorac Dis. 2018 Nov;10(Suppl 33): S4140–S4143.
- Sherrah A, Wilson M, Thomas S, et al. Haem-enzymes predictive of coronary artery disease Are present in thoracic and abdominal aortic aneurysm. Heart Lung Circ. 2017;26:S405. doi:https://doi.org/10.1016/j.hlc.2017.03.147.
- Raffort J, Lareyre F, Clément M, et al. Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol. 2017;14:457. doi:https://doi.org/10.1038/nrcardio.2017.52.
- Kim HW, Blomkalns AL, Ogbi M, et al. Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine. Am J Physiol Heart Circ Physiol. 2017 Dec 1;313(6):H1168–h1179. doi:https://doi.org/10.1152/ajpheart.00296.2017.
- Ollikainen E, Tulamo R, Lehti S, et al. Myeloperoxidase associates with degenerative remodeling and rupture of the saccular intracranial aneurysm wall. J Neuropathol Exp Neurol. 2018;77(6):461–468. doi:https://doi.org/10.1093/jnen/nly028.
- Chu Y, Wilson K, Gu H, et al. Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice. Stroke. 2015 Jun;46(6):1651–1656. doi:https://doi.org/10.1161/strokeaha.114.008589.
- Pitanga TN, Franca LD, Rocha VCJ, et al. Neutrophil-derived microparticles induce myeloperoxidase-mediated damage of vascular endothelial cells. BMC Cell Biol. 2014;15(1):21. doi:https://doi.org/10.1186/1471-2121-15-21.
- Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharm Ther. 2006;111(1):16–26. doi:https://doi.org/10.1016/j.pharmthera.2005.06.023.
- Aratani Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018;640:47–52. doi:https://doi.org/10.1016/j.abb.2018.01.004.
- Nauseef WM. Myeloperoxidase in human neutrophil host defence. Cell Microbiol. 2014;16(8):1146–1155. doi:https://doi.org/10.1111/cmi.12312.
- Malle E, Waeg G, Schreiber R, et al. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem. 2000 Jul;267(14):4495–4503.
- Stocker R, Huang A, Jeranian E, et al. Hypochlorous acid impairs endothelium-derived nitric oxide bioactivity through a superoxide-dependent mechanism. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2028–2033. doi:https://doi.org/10.1161/01.ATV.0000143388.20994.fa.
- Xu J, Xie Z, Reece R, et al. Uncoupling of endothelial nitric oxidase synthase by hypochlorous acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2688–2695. doi:https://doi.org/10.1161/01.atv.0000249394.94588.82.
- Mu H, Wang X, Lin P, et al. Nitrotyrosine promotes human aortic smooth muscle cell migration through oxidative stress and ERK1/2 activation. Biochim Biophys Acta Mol Cell Res. 2008;1783(9):1576–1584. doi:https://doi.org/10.1016/j.bbamcr.2008.04.004.
- Mu H, Wang X, Lin PH, et al. Chlorotyrosine promotes human aortic smooth muscle cell migration through increasing superoxide anion production and ERK1/2 activation. Atherosclerosis. 2008;201(1):67–75. doi:https://doi.org/10.1016/j.atherosclerosis.2007.12.049.
- Petsophonsakul P, Furmanik M, Forsythe R, et al. Role of vascular smooth muscle cell phenotypic switching and calcification in aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2019;39(7):1351–1368. doi:https://doi.org/10.1161/ATVBAHA.119.312787.
- Mehrkens D, Dohr JK, Mollenhauer M, et al. P4551 myeloperoxidase activity aggravates aortic wall remodeling and participates in aneurysm development in Marfan syndrome. Eur H Journal. 2018;39(suppl_1). doi:https://doi.org/10.1093/eurheartj/ehy563.P4551.
- Ali OA, Chapman M, Nguyen TH, et al. Interactions between inflammatory activation and endothelial dysfunction selectively modulate valve disease progression in patients with bicuspid aortic valve. Heart. 2014;100(10):800–805. doi:https://doi.org/10.1136/heartjnl-2014-305509.
- van de Pol V, Kurakula K, DeRuiter MC, et al. Thoracic aortic aneurysm development in patients with Bicuspid Aortic Valve: what Is the Role of Endothelial cells? Front Physiol. 2017;8. doi:https://doi.org/10.3389/fphys.2017.00938.
- Lomeli O, Perez-Torres I, Marquez R, et al. The evaluation of flow-mediated vasodilation in the brachial artery correlates With endothelial dysfunction evaluated by Nitric Oxide synthase metabolites in Marfan syndrome patients. Front Physiol. 2018;9:965. doi:https://doi.org/10.3389/fphys.2018.00965.
- Soto ME, Guarner-Lans V, Herrera-Morales KY, et al. Participation of arachidonic acid metabolism in the aortic aneurysm formation in patients with Marfan syndrome. Front Physiol. 2018;9. doi:https://doi.org/10.3389/fphys.2018.00077.
- Gerasimos S, Konstantinos M, Evangelos O, et al. The role of endothelial dysfunction in aortic aneurysms. Curr Pharm Des. 2015;21(28):4016–4034. doi:https://doi.org/10.2174/1381612821666150826094156.
- Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and Nitric Oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120(4):713–735. doi:https://doi.org/10.1161/CIRCRESAHA.116.309326.
- Lu D, Kassab GS. Role of shear stress and stretch in vascular mechanobiology. J R Soc Interface. 2011;8(63):1379–1385. doi:https://doi.org/10.1098/rsif.2011.0177.
- Osto E, Cosentino F. Chapter 22 - The role of oxidative stress in endothelial dysfunction and vascular inflammation. In Ignarro, LJ, editor. Nitric oxide (2nd ed.). San Diego: Academic Press; 2010. p. 705–754.
- Fan LM, Douglas G, Bendall JK, et al. Endothelial cell–specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation. 2014;129(25):2661–2672. doi:https://doi.org/10.1161/CIRCULATIONAHA.113.005062.
- Kim YH, Kim JS, Choi J-W, et al. Clinical implication of aortic wall biopsy in Aortic Valve disease with Bicuspid valve pathology. Korean J Thorac Cardiovasc Surg. 2016;49(6):443–450. doi:https://doi.org/10.5090/kjtcs.2016.49.6.443.
- Mohamed SA, Radtke A, Saraei R, et al. Locally different endothelial nitric oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve. Cardiol Res Pract. 2012. doi:https://doi.org/10.1155/2012/165957.
- Aicher D, Urbich C, Zeiher A, et al. Endothelial nitric oxide synthase in bicuspid aortic valve disease. Ann Thorac Surg. 2007 Apr;83(4):1290–1294. doi:https://doi.org/10.1016/j.athoracsur.2006.11.086.
- Lee TC, Zhao YD, Courtman DW, et al. Abnormal aortic valve development in mice lacking endothelial Nitric oxide synthase. Circulation. 2000;101(20):2345–2348. doi:https://doi.org/10.1161/01.cir.101.20.2345.
- Kotlarczyk MP, Billaud M, Green BR, et al. Regional disruptions in Endothelial Nitric Oxide pathway associated with Bicuspid Aortic valve. Ann Thorac Surg. 2016 Oct;102(4):1274–1281. doi:https://doi.org/10.1016/j.athoracsur.2016.04.001.
- Huang K, Wang Y, Siu KL, et al. Targeting feed-forward signaling of TGFβ/NOX4/DHFR/eNOS uncoupling/TGFβ axis with anti-TGFβ and folic acid attenuates formation of aortic aneurysms: novel mechanisms and therapeutics. Redox Biol. 2021;38. doi:https://doi.org/10.1016/j.redox.2020.101757.
- Daiber A, Xia N, Steven S, et al. New therapeutic Implications of Endothelial Nitric Oxide synthase (eNOS) function/dysfunction in cardiovascular disease. Int J Mol Sci. 2019;20(1):187. doi:https://doi.org/10.3390/ijms20010187.
- Karbach S, Wenzel P, Waisman A, et al. eNOS uncoupling in cardiovascular diseases–the role of oxidative stress and inflammation. Curr Pharm Des. 2014;20(22):3579–3594. doi:https://doi.org/10.2174/13816128113196660748.
- Siu KL, Cai H. Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm. Am J Physiol Heart Circ Physiol. 2014;307(11):H1559–H1564. doi:https://doi.org/10.1152/ajpheart.00444.2014.
- Gao L, Siu Kin L, Chalupsky K, et al. Role of uncoupled endothelial Nitric oxide synthase in abdominal aortic aneurysm formation. Hypertension. 2012;59(1):158–166. doi:https://doi.org/10.1161/HYPERTENSIONAHA.111.181644.
- Oller J, Méndez-Barbero N, Ruiz EJ, et al. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat Med. 2017;23(2):200–212. doi:https://doi.org/10.1038/nm.4266.
- Pautz A, Art J, Hahn S, et al. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010;23(2):75–93. doi:https://doi.org/10.1016/j.niox.2010.04.007.
- Di Meo S, Venditti P. Evolution of the knowledge of free radicals and other oxidants. Oxid Med Cell Longev. 2020. doi:https://doi.org/10.1155/2020/9829176.
- Griendling KK, Touyz RM, Zweier JL, et al. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system. Circ Res. 2016;119(5):e39–e75. doi:https://doi.org/10.1161/RES.0000000000000110.
- Schmidt HHHW, Stocker R, Vollbracht C, et al. Antioxidants in translational medicine. Antioxid Redox Signal. 2015;23(14):1130–1143. doi:https://doi.org/10.1089/ars.2015.6393.
- Bredemeier M, Lopes LM, Eisenreich MA, et al. Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord. 2018;18(1):24. doi:https://doi.org/10.1186/s12872-018-0757-9.
- Daiber A, Chlopicki S. Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies. Free Radic Biol Med. 2020;157:15–37. doi:https://doi.org/10.1016/j.freeradbiomed.2020.02.026.
- Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention systematic review and meta-analysis. JAMA. 2007;297(8):842–857. doi:https://doi.org/10.1001/jama.297.8.842.
- Davies A M, Holt A G. Why antioxidant therapies have failed in clinical trials. J Theor Biol. 2018;457:1–5. doi:https://doi.org/10.1016/j.jtbi.2018.08.014.
- Cuadrado A, Manda G, Hassan A, et al. Transcription factor NRF2 as a therapeutic target for chronic diseases: A systems Medicine approach. Pharmacol Rev. 2018;70(2):348. doi:https://doi.org/10.1124/pr.117.014753.
- Zhou H, Wang Y, You Q, et al. Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present). Expert Opin Ther Pat. 2020;30(3):209–225. doi:https://doi.org/10.1080/13543776.2020.1715365.
- Zhu S, Zhu K, Li J, et al. Nano-biomaterials for the delivery of therapeutic and monitoring cues for aortic diseases. Front Bioeng Biotechnol. 2020;8. doi:https://doi.org/10.3389/fbioe.2020.583879.
- Habibalahi A, Moghari MD, Campbell JM, et al. Non-invasive real-time imaging of reactive oxygen species (ROS) using auto-fluorescence multispectral imaging technique: A novel tool for redox biology. Redox Biol. 2020 Jul;34. doi:https://doi.org/10.1016/j.redox.2020.101561.
- Berkowitz BA. Oxidative stress measured in vivo without an exogenous contrast agent using QUEST MRI. J Magn Reson. 2018 Jun;291:94–100. doi:https://doi.org/10.1016/j.jmr.2018.01.013.